Travere Therapeutics's total assets for Q3 2024 were $504.41M, a decrease of -8.48% from the previous quarter. TVTX total liabilities were $534.86M for the fiscal quarter, a -0.21% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.